Drug Type Small molecule drug |
Synonyms- |
Target |
Action modulators |
Mechanism CLEC4M modulators(C-type lectin domain family 4 member M modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H25ClN6O5 |
InChIKeyGQIBSYVLMOXPCQ-ITGHMWBKSA-N |
CAS Registry3076489-50-1 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| COVID-19 | Preclinical | Italy | 18 Oct 2025 |





